Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 18.00
+0.40 (2.27%)
Oct 30, 2026, 1:44 PM IST
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 210.26 million as of October 30, 2026. It is the 28,061st most valuable company in the world and the 330th biggest in Israel. Its market cap has decreased by 17.79% in one year.
Market Cap
210.26M
Enterprise Value
218.00M
Revenue
n/a
Global Rank
Country Rank
#330 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 210.26M, an increase of 1,600.81%. That is a compound annual growth rate of 21.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 206.76M | -29.47% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matricelf | 82.73M |
| Clal Biotechnology Industries | 36.07M |
| Purple Biotech | 32.42M |
| BioLineRx | 29.87M |
| BioLight Life Sciences | 28.38M |
| Evogene | 18.93M |
| XTL Biopharmaceuticals | 18.54M |
| Can-Fite BioPharma | 15.94M |